Hormone Replacement Therapy: Difference between revisions

No edit summary
No edit summary
Line 6: Line 6:
</div>  
</div>  


<div class="noeditbox">This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! ({{REVISIONDAY}}/{{REVISIONMONTH}}/{{REVISIONYEAR}})</div>


== Introduction ==
== Introduction ==

Revision as of 00:44, 17 August 2022

Original Editor - Habibu salisu Badamasi

Top Contributors - Habibu Salisu Badamasi, Lucinda hampton and Niha Mulla

This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (17/08/2022)

Introduction[edit | edit source]

Menopause is a physiological change that occurs in women around the age of 51. Hormone replacement therapy (HRT) combines estrogen with a progestogen to protect the endometrium in women who still have their uterus. [1]Hormone replacement therapy (HRT) is a menopause treatment that relieves symptoms. As you approach menopause, it replaces hormones that are at a lower level.[2]

AdobeStock 327509111.jpg
Hormone Replacement Therapy.

Types of hormone replacement therapy[edit | edit source]

Hormone replacement therapy (HRT) - most women take a combination of estrogen, progestogen, and estrogen alone.[2] Oral, intravaginal, or transdermal estrogen (oestradiol, oestradiol 17, oestrone, or conjugated equine estrogen) The progestogen can be taken orally, applied topically, or administered through an intrauterine device . Estrogen is used daily in HRT regimens, with progestogen added sequentially (cyclic regimen) or daily (continuous combined regimen) as needed. Tibolone is a synthetic steroid that has estrogenic, androgenic, and progestogenic effects and can be taken as HRT. HRT can be supplemented with testosterone.[1]

  • Progestins
  • Tibolone
  • Testosterone
  • Dehydroepiandrosterone
  • Custom Compounding

Indications of hormone replacement therapy[edit | edit source]

The presence of bothersome vasomotor symptoms is the main indication for HRT. Vasomotor symptoms are common during the menopause transition and affect about 80% of women, and are severe in about 20% of these women. The duration of these symptoms varies, with a median of four years, but may continue for as many as 12 years in about 10% of women. HRT may be indicated when menopausal symptoms are adversely affecting quality of life.[1]

vasomotor symptoms[edit | edit source]
  • Hot flushes
  • Night sweats
  • with or without awakening.

Benefits of hormone replacement therapy[edit | edit source]

  1. Menopausal symptoms: HRT is widely used for the established indications of menopausal symptoms.
  2. Osteoporotic fractures: an older population with severe osteoporosis might have enjoyed greater protection from fractures with HRT. Some studies also found that the use of HRT reduces vertebral and hip fractures.
  3. Cardiovascular Disease: HRT is used for high cholesterol levels and for coronary heart disease. Hence, for primary prevention of cardiovascular disease.
  4. Women who use HRT have a significantly lower risk of disease and death than women who do not.
  5. Breast cancer: The risk of metastases among breast cancer patients who had used HRT was significantly decreased; this suggests that these cancers were localized to the breast and potentially had a better prognosis.
  6. Colorectal cancer: Studies suggest that estrogen reduces the risk of colorectal cancer. other studies found out that HRT brings about protection of colorectal cancer with increased in duration of use.
  7. Brain: some studies have found out that may have effect on the brain. A beneficial effect on verbal memory, vigilance, motor speed, and reasoning on symptomatic women.

[3]

Risks of hormone replacement therapy.[edit | edit source]

Harms of HRT include coronary heart disease, stroke, and thromboembolism (especially during early use). The risk of breast cancer and cholecystitis increases with longer use.[4]

References[edit | edit source]

  1. 1.0 1.1 1.2 Hickey M, Elliott J, Davison SL. Hormone replacement therapy. Bmj. 2012 Feb 16;344.
  2. 2.0 2.1 Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertility and sterility. 2016 Dec 1;106(7):1588-99.
  3. Benefit of Hormone Replacement Therapy Available from https://www.youtube.com/watch?reload=9&app=desktop&v=Bin4GEf7-TI Accessed on 31/05/2022
  4. Grimes DA, Lobo RA. Perspectives on the Women’s Health Initiative trial of hormone replacement therapy. Obstetrics & Gynecology. 2002 Dec 1;100(6):1344-53.